查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538445

肾上腺皮质荷尔蒙API 市场报告：2030 年趋势、预测与竞争分析

Adrenocortical Hormone API Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

肾上腺皮质荷尔蒙API的趋势与预测

预计 2024 年至 2030 年，全球肾上腺皮质荷尔蒙API 市场将以 5.9% 的复合年增长率成长。该市场的主要驱动因素是对荷尔蒙补充疗法的需求不断增长以及肾上腺功能不全疾病盛行率的上升。全球肾上腺皮质荷尔蒙API 市场的未来充满希望，注射、口服、外用和吸入市场充满机会。

肾上腺皮质荷尔蒙API：按细分市场

该研究包括按类型、应用和地区分類的全球肾上腺皮质荷尔蒙API 的预测。

肾上腺皮质荷尔蒙API 市场洞察

Lucintel 预测泼尼松系列将出现最高的成长。

注射剂预计将在该市场中成长最快。

预计北美地区的成长最快。

常问问题

Q1.市场成长预测是多少：

A1. 2024年至2030年，全球肾上腺皮质荷尔蒙API市场预计将以5.9%的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 该市场的主要驱动力是荷尔蒙补充疗法的需求不断增长以及肾上腺功能不全疾病的盛行率上升。

Q3.市场的主要细分市场是：

A3.肾上腺皮质荷尔蒙原料药市场的未来充满希望，注射剂、口服剂、外用剂和吸入剂市场都有机会。

Q4.市场的主要企业是：

A4. 主要肾上腺皮质荷尔蒙原料药公司如下：

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Q5.未来最大的细分市场是什么？

A5.Lucintel预测泼尼松系列将经历最高的成长。

Q6.未来五年预计哪些地区的市场成长最大？

A6 预计北美地区成长最快。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球肾上腺皮质荷尔蒙API 市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球肾上腺皮质荷尔蒙API市场趋势（2018-2023）与预测（2024-2030）
  • 全球肾上腺皮质荷尔蒙API 市场：按类型
    • 泼尼松系列
    • 地塞米松系列
    • Betamethasone系列
    • Hydrocortisone系列
    • 其他的
  • 全球肾上腺皮质荷尔蒙API 市场：依应用分类
    • 注射
    • 口服剂
    • 外用製剂
    • 吸入剂

第四章 2018-2030年区域市场趋势及预测分析

  • 全球肾上腺皮质荷尔蒙API 市场（按地区）
  • 北美肾上腺皮质荷尔蒙原料药市场
  • 欧洲肾上腺皮质荷尔蒙原料药市场
  • 亚太地区肾上腺皮质荷尔蒙原料药市场
  • 其他地区肾上腺皮质荷尔蒙原料药市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球肾上腺皮质荷尔蒙原料药市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球肾上腺皮质荷尔蒙原料药市场产能扩张
    • 全球肾上腺皮质荷尔蒙API 市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
简介目录

Adrenocortical Hormone API Trends and Forecast

The future of the global adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets. The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2024 to 2030. The major drivers for this market are growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Adrenocortical Hormone API by Segment

The study includes a forecast for the global adrenocortical hormone API by type, application, and region.

Adrenocortical Hormone API Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Prednisone Series
  • Dexamethasone Series
  • Betamethasone Series
  • Hydrocortisone Series
  • Others

Adrenocortical Hormone API Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Injectable Drug
  • Oral Drug
  • For External Use Drug
  • Inhalation Drug

Adrenocortical Hormone API Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Adrenocortical Hormone API Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adrenocortical hormone API companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adrenocortical hormone API companies profiled in this report include-

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Adrenocortical Hormone API Market Insights

Lucintel forecasts that prednisone series is expected to witness the highest growth.

Within this market, injectable drug is expected to witness the highest growth.

North America is expected to witness the highest growth.

Features of the Global Adrenocortical Hormone API Market

Market Size Estimates: Adrenocortical hormone API market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Adrenocortical hormone API market size by type, application, and region in terms of value ($B).

Regional Analysis: Adrenocortical hormone API market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adrenocortical hormone API market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adrenocortical hormone API market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for adrenocortical hormone API market?

Answer: The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the adrenocortical hormone API market?

Answer: The major drivers for this market are growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

Q3. What are the major segments for adrenocortical hormone API market?

Answer: The future of the adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets.

Q4. Who are the key adrenocortical hormone API market companies?

Answer: Some of the key adrenocortical hormone API companies are as follows:

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Q5. Which adrenocortical hormone API market segment will be the largest in future?

Answer: Lucintel forecasts that prednisone series is expected to witness the highest growth.

Q6. In adrenocortical hormone API market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the adrenocortical hormone API market by type (prednisone series, dexamethasone series, betamethasone series, hydrocortisone series, and others), application (injectable drug, oral drug, for external use drug, and inhalation drug), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Adrenocortical Hormone API Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Adrenocortical Hormone API Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Adrenocortical Hormone API Market by Type
    • 3.3.1: Prednisone Series
    • 3.3.2: Dexamethasone Series
    • 3.3.3: Betamethasone Series
    • 3.3.4: Hydrocortisone Series
    • 3.3.5: Others
  • 3.4: Global Adrenocortical Hormone API Market by Application
    • 3.4.1: Injectable Drug
    • 3.4.2: Oral Drug
    • 3.4.3: For External Use Drug
    • 3.4.4: Inhalation Drug

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Adrenocortical Hormone API Market by Region
  • 4.2: North American Adrenocortical Hormone API Market
    • 4.2.1: North American Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.2.2: North American Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.3: European Adrenocortical Hormone API Market
    • 4.3.1: European Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.3.2: European Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.4: APAC Adrenocortical Hormone API Market
    • 4.4.1: APAC Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.4.2: APAC Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.5: ROW Adrenocortical Hormone API Market
    • 4.5.1: ROW Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.5.2: ROW Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Adrenocortical Hormone API Market by Type
    • 6.1.2: Growth Opportunities for the Global Adrenocortical Hormone API Market by Application
    • 6.1.3: Growth Opportunities for the Global Adrenocortical Hormone API Market by Region
  • 6.2: Emerging Trends in the Global Adrenocortical Hormone API Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Adrenocortical Hormone API Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adrenocortical Hormone API Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer CentreOne
  • 7.2: EuroAPI
  • 7.3: GlaxoSmithKline
  • 7.4: Teva Pharmaceutical Industries
  • 7.5: Hovione
  • 7.6: Axplora
  • 7.7: Steroid Spa
  • 7.8: Avik Pharmaceutical
  • 7.9: Anuh Pharma
  • 7.10: Symbiotec Pharmalab